Cite
HARVARD Citation
Céspedes, P. et al. (2017). A single, low dose of a cGMP recombinant BCG vaccine elicits protective T cell immunity against the human respiratory syncytial virus infection and prevents lung pathology in mice. Vaccine. 35 (5), pp. 757-766. [Online].